Dear colleagues,
It is with a mix of emotions that I pen this editorial. After six years at the helm of the Department of Clinical Science, I have decided to step down from my position as Department Head. This decision has not been taken lightly, but rather with careful consideration of the demands and responsibilities that come with leading such a dynamic and impactful department.
Our department, a hub of research and teaching excellence, has grown significantly during my tenure. With 382 dedicated employees, including 70 full-time professors and associated professors, 80 part-time professors and associated professors, over 180 researchers, podt docs and PhD students as well as 50 technicians and administrative staff , we have made significant strides in advancing clinical and translational medical research. This means that in 2023, we had publications in top-tier journals and set a record for external funding: 121 million NOK. You teach a variety of clinical specialties in addition to pharmacy and nutrition in an exemplary manner. And you have excelled in the competition to establish several new and robust research centers.
However, as the demands of leadership have intensified, I find myself at a crossroads. Balancing the responsibilities of both Department Head and Director of the Mohn Center of Diabetes Precision Medicine has been challenging. The pursuit of excellence requires focus, and I believe it is time to pass the torch to a new leader who can continue to push our department forward.
I am immensely proud of what we have achieved together. Our collaborative spirit, dedication to patient care, and groundbreaking research have left an indelible mark. As I step down, I am confident that the department will continue to thrive under new leadership.
I will be stepping down on April 30, 2024, and in the coming period, I will gradually transfer my responsibilities to Eystein Husebye, who will serve as the Acting Department Head. Rest assured, I remain committed to our shared mission, and I look forward to contributing to the department in new ways. My decision is not a farewell but rather a shift in roles—one that allows me to focus on the exciting work happening at the Mohn Center.
I extend my heartfelt gratitude to each of you for your unwavering support and dedication. Together, we have made a difference in the lives of patients and the future of medicine. Let us continue to collaborate, innovate, and inspire.
Thank you for being part of this remarkable journey.
As we embark on a new chapter at the Department of Clinical Science, I am thrilled to announce two additions to our leadership team:
Professor Svein Skeie, MD, PhD: An accomplished endocrinologist and Head of Research at Stavanger University Hospital, Svein Skeie will assume the role of Leader of Stavanger Relations. His deep understanding of leadership, clinical practice, and research will serve as a valuable link between our institutions. The collaboration with Stavanger University Hospital promises to strengthen our ties and foster innovative initiatives.
Professor Silje Skrede, MD, PhD: With a background in pharmacology and administrative work in teaching, Skrede joins us as Leader of Innovation which will strengthen our focus on this important field. Skrede will temporary act as Leader of Teaching while Mette Vesterhus is away.
Enjoy the week-end!
Pål
